Rare diseases
Investigational molecules
Locations
Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients
SpainStudy on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients
SpainStudy of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer
SpainStudy on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias
SpainStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
SpainStudy on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant
SpainStudy on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System
SpainStudy for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment
SpainStudy of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer
SpainStudy on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
SpainStudy of Sacituzumab and Zimberelimab for Patients with Resectable Non-Small Cell Lung Cancer After Surgery Without Complete Disease Clearance
SpainStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
